Remimazolam vs. propofol for total intravenous anesthesia: a systematic review of hemodynamic stability and recovery profiles
Remimazolam is an ultra-short-acting benzodiazepine that has been developed as a new option for total intravenous anesthesia (TIVA) and might have benefits in terms of hemodynamic stability and recovery profiles. The purpose of this systematic review was to compare the hemodynamic stability and recovery between remimaz...